1. Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist 177Lu‐DOTAGA‐PEG2‐RM26
   Bogdan Mitran et al, 2019, International Journal of Cancer CrossRef
2. Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound
   Chun-Han Lin et al, 2017, Cell Reports CrossRef